|
2024
|
Invention
|
Human neutralizing antibodies against hiv env. The present disclosure relates to anti-HIV antibod... |
|
|
Invention
|
Multispecific anti-hiv antibodies. The present disclosure relates to anti-HIV Env antibodies and ... |
|
2023
|
Invention
|
Rapid elicitation of broadly neutralizing bovine antibodies to hiv env.
The present disclosure r... |
|
|
Invention
|
H-based scaffold for the production of single domain antibodies and their use. Provided herein ar... |
|
|
Invention
|
Anti-venom antibodies and uses thereof. In one aspect, provided herein is a method for the synthe... |
|
2022
|
Invention
|
Broadly neutralizing antibody and uses thereof. 50 of 0.003 μg/ml, compositions containing the sa... |
|
2021
|
Invention
|
Replication-competent adenovirus type 4-hiv env vaccines and their use. Replication-competent ade... |
|
|
Invention
|
Modified immunogenic proteins. The invention relates to germline-targeting designs, stabilization... |
|
2020
|
Invention
|
Engineered antibodies to hiv env.
The present disclosure relates to anti-HIV Env antibodies and ... |
|
|
Invention
|
Engineered antibodies to hiv env. The present disclosure relates to anti-HIV Env antibodies and t... |
|
2019
|
Invention
|
Recombinant hiv env polypeptides and their uses.
The present disclosure relates to recombinant H... |
|
|
Invention
|
Recombinant hiv env polypeptides and their uses. The present disclosure relates to recombinant HI... |
|
|
Invention
|
Recombinant hiv env polypeptides and their use. The present disclosure relates to recombinant HIV... |
|
|
Invention
|
Anti-hiv antibodies.
The present disclosure relates to anti-HIV Env antibodies and their use in ... |
|
|
Invention
|
Anti-hiv antibodies. The present disclosure relates to anti-HIV Env antibodies and their use in t... |
|
|
Invention
|
Multispecific antibodies targeting multiple epitopes on the hiv-1 envelope. The present invention... |
|
|
Invention
|
Multispecfic anti-hiv antibodies. The present invention provides a multispecific anti-HIV antibod... |
|
|
Invention
|
Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus t... |
|
|
Invention
|
Enginerred antibodies to hiv env.
The present disclosure relates to anti-HIV Env antibodies and ... |
|
|
Invention
|
Monoclonal antibodies directed against trimeric forms of the hiv-1 envelope glycoprotein with bro... |
|
|
Invention
|
Ferritin nanoparticle displaying an hiv trimer.
The present invention relates to glycosylate HIV... |
|
|
Invention
|
Ferritin nanoparticle displaying an hiv trimer. The present invention relates to glycosylate HIV ... |
|
|
Invention
|
Optimized hiv envelope gene and expression thereof. The present invention relates to a vector(s) ... |
|
|
Invention
|
Engineered outer domain (eod) of hiv gp120 and mutants thereof. The invention relates to an engin... |
|
|
Invention
|
Transgenic vero-cd4/ccr5 cell line. The present relation relates to a transgenic Vero cell line e... |
|
|
Invention
|
Recombinant viral vectors. The present relation relates to recombinant vesicular stomatitis virus... |
|
2018
|
Invention
|
Immunogenic trimers. The invention relates to PGT121-germline-targeting designs, trimer stabiliza... |
|
|
Invention
|
N-glycan deleted hiv-1 envelope glycoprotein trimers. The present application relates to novel HI... |
|
|
Invention
|
Rapid elicitation of broadly neutralizing antibodies to hiv env. The present disclosure relates t... |
|
|
Invention
|
Mini-protein immunogens displayng neutralization epitopes for respiratory syncytial virus (rsv). ... |
|
|
Invention
|
Nanoparticle immunogens to elicit responses against the influenza receptor binding site on the he... |
|
2017
|
Invention
|
Engineered outer domain (eod) of hiv gp120, mutants and use thereof. The present invention relate... |
|
|
Invention
|
Multispecific antibodies targeting human immunodeficiency virus and methods of using the same. Th... |
|
|
Invention
|
Broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibo... |
|
|
Invention
|
Genetically stable replication competent sendai virus vector(s) containing and expressing optimiz... |
|
|
Invention
|
Vesicular stomatitis virus and virus rescue system. The present relation relates to recombinant v... |
|
2016
|
Invention
|
Replication-competent vsv-hiv env vaccines. The present relation relates to recombinant vesicular... |
|
|
Invention
|
Hiv-1 clade c envelope glycoproteins. A major focus of HIV-1 vaccine research is to design an imm... |
|
2014
|
Invention
|
Soluble hiv-1 envelope glycoprotein trimers. The present application relates to novel HIV-1 envel... |
|
2011
|
Invention
|
Human immunodeficiency virus (hiv)-neutralizing antibodies. The invention provides a method for o... |
